The National Niemann-Pick Type C1 Disease Database: correlation of lipid profiles, mutations, and biochemical phenotypes
- PMID: 19744920
- PMCID: PMC2803243
- DOI: 10.1194/jlr.P000331
The National Niemann-Pick Type C1 Disease Database: correlation of lipid profiles, mutations, and biochemical phenotypes
Abstract
Niemann-Pick type C1 disease (NPC1) is an autosomal recessive lysosomal storage disorder characterized by neonatal jaundice, hepatosplenomegaly, and progressive neurodegeneration. The present study provides the lipid profiles, mutations, and corresponding associations with the biochemical phenotype obtained from NPC1 patients who participated in the National NPC1 Disease Database. Lipid profiles were obtained from 34 patients (39%) in the survey and demonstrated significantly reduced plasma LDL cholesterol (LDL-C) and increased plasma triglycerides in the majority of patients. Reduced plasma HDL cholesterol (HDL-C) was the most consistent lipoprotein abnormality found in male and female NPC1 patients across age groups and occurred independent of changes in plasma triglycerides. A subset of 19 patients for whom the biochemical severity of known NPC1 mutations could be correlated with their lipid profile showed a strong inverse correlation between plasma HDL-C and severity of the biochemical phenotype. Gene mutations were available for 52 patients (59%) in the survey, including 52 different mutations and five novel mutations (Y628C, P887L, I923V, A1151T, and 3741_3744delACTC). Together, these findings provide novel information regarding the plasma lipoprotein changes and mutations in NPC1 disease, and suggest plasma HDL-C represents a potential biomarker of NPC1 disease severity.
Figures
References
-
- Patterson M. C., Vanier M. T., Suzuki K., Morris J. E., Carstea E. D., Neufeld E. B., Blanchette-Mackie E. J., Pentchev P. G. 2001. Niemann-Pick Disease Type C: a lipid trafficking disorder. The Metabolic and Molecular Bases of Inherited Disease. 8th edition C. R. Beaudet A. L., Sly W. S., Valle D., McGraw-Hill, New York: 3611–3633.
-
- Vanier M. T., Wenger D. A., Comly M. E., Rousson R., Brady R. O., Pentchev P. G. 1988. Niemann-Pick disease group C: clinical variability and diagnosis based on defective cholesterol esterification. A collaborative study on 70 patients. Clin. Genet. 33: 331–348. - PubMed
-
- Vanier M. T., Rodriguez-Lafrasse C., Rousson R., Gazzah N., Juge M. C., Pentchev P. G., Revol A., Louisot P. 1991. Type C Niemann-Pick disease: spectrum of phenotypic variation in disruption of intracellular LDL-derived cholesterol processing. Biochim. Biophys. Acta. 1096: 328–337. - PubMed
-
- Vanier M. T., Rodriguez-Lafrasse C., Rousson R., Duthel S., Harzer K., Pentchev P. G., Revol A., Louisot P. 1991. Type C Niemann-Pick disease: biochemical aspects and phenotypic heterogeneity. Dev. Neurosci. 13: 307–314. - PubMed
-
- Fink J. K., Filling-Katz M. R., Sokol J., Cogan D. G., Pikus A., Sonies B., Soong B., Pentchev P. G., Comly M. E., Brady R. O., et al. 1989. Clinical spectrum of Niemann-Pick disease type C. Neurology. 39: 1040–1049. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
